Evidence map›Paper›PMID 31441361›Full record

ArticleIntegrative cancer therapies

Curcumin Acts as a Chemosensitizer for Leiomyosarcoma Cells In Vitro But Fails to Mediate Antioxidant Enzyme Activity in Cisplatin-Induced Experimental Nephrotoxicity in Rats.

Irida Dhima, Stelios Zerikiotis, Panagiotis Lekkas, Yannis V Simos, Maria Gkiouli, Patra Vezyraki, Evangelia Dounousi, Vasilios Ragos, Xenophon Giannakopoulos, Dimitrios Baltogiannis and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Irida Dhima1 University of Ioannina, Greece.
Stelios Zerikiotis1 University of Ioannina, Greece.
Panagiotis Lekkas1 University of Ioannina, Greece.
Yannis V Simos1 University of Ioannina, Greece.ORCID 0000-0003-1764-8906
Maria Gkiouli1 University of Ioannina, Greece.
Patra Vezyraki1 University of Ioannina, Greece.
Evangelia Dounousi1 University of Ioannina, Greece.
Vasilios Ragos1 University of Ioannina, Greece.
Xenophon Giannakopoulos1 University of Ioannina, Greece.
Dimitrios Baltogiannis1 University of Ioannina, Greece.
Vasiliki Kalfakakou1 University of Ioannina, Greece.
Angelos Evangelou1 University of Ioannina, Greece.
Dimitrios Peschos1 University of Ioannina, Greece.
Spyridon Karkabounas1 University of Ioannina, Greece.
University of Ioannina · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntineoplastic AgentsAntioxidantsApoptosisBlood Urea NitrogenCell LineCisplatinCreatinineCurcuminFemaleGlutathioneHumansKidneyKidney DiseasesLeiomyosarcomaLipid PeroxidationAntineoplastic AgentsAntioxidantsCisplatinCreatinineCurcuminGlutathioneSuperoxide Dismutasechemotherapycurcumincytotoxicitynephrotoxicityoxidative stress

Identifiers

PMID31441361
PMCPMC6710690
OpenAlexW2969867237

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.